Highlights
NASDAQ: MEIP       Mei Pharma Inc
Last Price Today's Change   Day's Range   Trading Volume
2.31   0.00 (0.00%)  0.00 - 0.00  0

Overview

 
Avg Volume (4 weeks):494,672
4 Weeks Range:1.975 - 2.58
4 Weeks Price Volatility (%):
89.53%
52 Weeks Range:1.44 - 3.41
52 Weeks Price Volatility (%):
67.74%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

MEI Pharma Inc is a San Diego-based oncology company focused on the clinical development of novel therapies for cancer. The company's clinical drug candidate includes Pracinostat, an orally available histone deacetylase inhibitor for the treatment of patients with acute myeloid leukemia and myelodysplastic syndrome. Its clinical development portfolio also includes ME-401, an oral inhibitor of phosphatidylinositide 3-kinase delta for the treatment of patients with recurrent chronic lymphocytic leukemia or follicular non-Hodgkin's lymphoma; and ME-344, an isoflavone-based mitochondrial inhibitor for the treatment of HER2-negative breast cancer. Geographically, all the business activities are functioned through the region of US.

  Be the first to like this.
 


 

8896 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 HIPS 17.070.00 
 HONE 11.030.00 
 ENZL 57.410.00 
 KOD 64.880.00 
 UPRO 72.870.00 
 COLD 35.090.00 
 UBIO 29.9460.00 
 ALYA 2.680.00 
 CIGI 82.100.00 
 AXNX 30.770.00 
Partners & Brokers